Treating insulin resistance: future prospects. (Q36806514)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Treating insulin resistance: future prospects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Clifford J Bailey

series ordinal

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and Vascular Disease Research

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

20-31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17469040%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

cites work

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Modulation of insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Insulin resistance and antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Glitazones and the management of insulin resistance: what they do and how might they be used

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Molecular basis for the insulinomimetic effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Cellular effects of small molecule PTP1B inhibitors on insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Vanadium compounds biological actions and potential as pharmacological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Virtual cloning, functional expression, and gating analysis of human connexin31.9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Prolonged glucose infusion into conscious rats inhibits early steps in insulin signalling and induces translocation of GLUT4 and protein kinase C in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Protein kinase Cbeta isoform inhibitors: a new treatment for diabetic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The effect of ruboxistaurin on nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Insulin-like effect of pinitol

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Enhanced insulin sensitivity, energy expenditure and thermogenesis in adipose-specific Pten suppression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PTEN targeting: the search for novel insulin sensitisers provides new insight into obesity research

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The lipid phosphatase SHIP2 controls insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Inflammatory status and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Interleukin-6 and insulin sensitivity: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Adipose tissue: from lipid storage compartment to endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Role of leptin in glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The role of leptin receptor signaling in feeding and neuroendocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Acute stimulation of glucose uptake by leptin in l6 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Resistin/ADSF/FIZZ3 in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Resistin, central obesity, and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Retinoid-binding proteins: mediators of retinoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The therapeutic use of lipoic acid in diabetes: a current perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Lipoic acid increases glucose uptake by skeletal muscles of obese-diabetic ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effect of ramipril on the incidence of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Traditional plant medicines as treatments for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Drugs on the horizon for diabesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

New pharmacologic agents for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Insulinlike Effects of Zinc Ion in Vitro and in Vivo: Preferential Effects on Desensitized Adipocytes and Induction of Normoglycemia in Streptozocin-Induced Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Reactive oxygen species have a causal role in multiple forms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The role of reactive oxygen species in insulin signaling in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Monitoring diabetic antioxidant status: a role for in vitro methaemoglobin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Vitamin supplement use and diabetes mellitus incidence among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Human insulin resistance: the role of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Long-term AICAR administration and exercise prevents diabetes in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002

The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.002